MSEQX
Price
$56.97
Change
+$1.84 (+3.34%)
Updated
May 8 closing price
Net Assets
3.77B
RGEBX
Price
$69.59
Change
+$0.51 (+0.74%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

MSEQX vs RGEBX

Header iconMSEQX vs RGEBX Comparison
Open Charts MSEQX vs RGEBXBanner chart's image
Morgan Stanley Inst Growth I
Price$56.97
Change+$1.84 (+3.34%)
VolumeN/A
Net Assets3.77B
American Funds Growth Fund of Amer R2E
Price$69.59
Change+$0.51 (+0.74%)
VolumeN/A
Net Assets283.8B
MSEQX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSEQX vs. RGEBX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSEQX is a Buy and RGEBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 284B vs. MSEQX (3.77B). MSEQX pays higher dividends than RGEBX: MSEQX (0.57) vs RGEBX (0.00). MSEQX was incepted earlier than RGEBX: MSEQX (34 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than MSEQX (0.56). MSEQX is a more actively managed with annual turnover of: 39.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than MSEQX: RGEBX (250) vs MSEQX (1000000). MSEQX annual gain was more profitable for investors over the last year : 47.19 vs. RGEBX (2.88). RGEBX return over 5 years is better than : 40.75 vs. MSEQX (-6.51).
MSEQXRGEBXMSEQX / RGEBX
Total Expense Ratio0.561.0951%
Annual Report Gross Expense Ratio0.561.0951%
Fund Existence34 years11 years-
Gain YTD-1.641-2.59063%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.77B284B1%
Annual Yield % from dividends0.570.00-
Returns for 1 year47.192.881,637%
Returns for 3 years62.0132.03194%
Returns for 5 years-6.5140.75-16%
Returns for 10 years31.7954.7558%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDRX4.240.45
+11.87%
GoodRx Holdings
KAVL0.600.03
+4.37%
Kaival Brands Innovations Group
PNR93.531.75
+1.91%
Pentair plc
SUPV14.60N/A
N/A
Grupo Supervielle SA
BDSX0.35-0.08
-17.91%
Biodesix